Dyslipidemia Stocks List

Dyslipidemia Stocks Recent News

Date Stock Title
Mar 27 ABT Abbott Hosts Conference Call for First-Quarter Earnings
Mar 27 VKTX Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
Mar 27 ABT Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark
Mar 27 VKTX IBD Stock Of The Day Eli Lilly Jumps Early Entry As Viking Charges Obesity Space
Mar 27 ARGX argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
Mar 26 ABT Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know
Mar 26 ARGX argenx Announces Annual General Meeting of Shareholders on May 7, 2024
Mar 26 VKTX Stocks Inch Higher, Tesla Rebounds, Bitcoin Holds Below $70,000: What's Driving Markets Tuesday?
Mar 26 VKTX Viking Therapeutics stock rises on positive Phase 1 weight-loss pill data
Mar 26 VKTX Why Viking Therapeutics Stock Is Skyrocketing Today
Mar 26 VKTX Viking Therapeutics stock surges on weight loss pill data
Mar 26 VKTX Viking Therapeutics Posts Promising Early Weight-Loss Data as Cost Worries Escalate
Mar 26 VKTX Viking Surges After Weight-Loss Pill — A Rival To Novo, Lilly — Beats Expectations In Just 28 Days
Mar 26 VKTX Viking Therapeutics' Investigational Oral Obesity Drug Shows Reduced Weight In Small Study
Mar 26 VKTX Viking Therapeutics: Buy, Sell, or Hold?
Mar 26 MDGL Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
Mar 26 VKTX Viking stays in obesity drug race with early data for weight loss pill
Mar 26 VKTX Viking Therapeutics gains on early data for oral weight loss therapy
Mar 26 VKTX Viking Therapeutics' weight-loss tablet shows promise in small study
Mar 26 VKTX Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
Dyslipidemia

Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle. Prolonged elevation of insulin levels can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.

Browse All Tags